首页 | 本学科首页   官方微博 | 高级检索  
     

BCL-6和BCL-2蛋白在弥漫大B细胞淋巴瘤中的表达及其临床意义
引用本文:孙冠星,曹祥山,李青. BCL-6和BCL-2蛋白在弥漫大B细胞淋巴瘤中的表达及其临床意义[J]. 临床荟萃, 2012, 27(8): 652-656
作者姓名:孙冠星  曹祥山  李青
作者单位:苏州大学附属第三医院常州市第一人民医院血液科,江苏常州,213003%苏州大学附属第三医院常州市第一人民医院病理科,江苏常州,213003
摘    要:目的 探讨BCL-6和BCL-2蛋白的表达与弥漫大B细胞淋巴瘤(diffuse large B-cell lymphoma,DLBCL)的临床特征及预后之间的关系.方法 应用免疫组织化学染色的方法检测BCL-6和BCL-2两种蛋白在46例DLBCL中的表达,并分析它们与DLBCL的临床特征及预后的关系.结果 BCL-6和BCL-2蛋白的阳性表达率分别为60.9%(28/46)和54.3%(25/46),BCL-6阳性组和BCL-2阴性组患者预后较好.结论 BCL-6和BCL-2的蛋白表达与DLBCL预后有一定相关性,可作为判断DLBCL预后的参考指标.

关 键 词:高血压  心房颤动  左心房内径  心电描记术  

Expression and clinical significance of BCL-6 and BCL-2 in diffuse large B-cell lymphoma
SUN Guan-xing , CAO Xiang-shan , LI Qing. Expression and clinical significance of BCL-6 and BCL-2 in diffuse large B-cell lymphoma[J]. Clinical Focus, 2012, 27(8): 652-656
Authors:SUN Guan-xing    CAO Xiang-shan    LI Qing
Affiliation:b a.Department of Hematology;b.Department of Pathology,the Third Affiliated Hospital of Soochow University,the First People's Hospital of Changzhou,Changzhou 213003,China
Abstract:Objective To investigate the relationship between BCL-6 and BCL-2 as well as the clinical features and prognosis of diffuse large B cell lymphoma(DLBCL). Methods Immunohistochemistry stain was used to determine the expression of BCL-6 and BCL-2. Results Positive rates of BCL-6 and BCL-2 were 60.9%(28/46) and 54.3%(25/46).BCL-6 positive and BCL-2 negative expression showed a trend to better overall survival(OS) and progression-free survival(PFS). Conclusion The results suggest significant correlationship among BCL-6,BCL-2 and prognosis.Moreover,BCL-6 and BCL-2 may be the useful prognostic indicators in diffuse large B cell lymphoma.
Keywords:lymphoma  large-cell  diffuse  proto-oncogene proteins c-bcl-6  proto-oncogene proteins c-bcl-2  prognosis
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《临床荟萃》浏览原始摘要信息
点击此处可从《临床荟萃》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号